Research and Markets - United States $15 Billion Proton Therapy Market, 2021 Featuring Elekta, IBA & Varian
DUBLIN, Apr. 10, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "United States Proton Therapy Market & Forecast, Reimbursement Policy, Patients Treated at Proton Therapy Centers" report to their offering.
The potential market of proton therapy in United States would be more than US$ 15 Billion by the end of 2021 and it is expected to grow with a CAGR of 6.04 percent in future.
At present the United States holds world's 40 percent of Proton Beam Therapy Facility. In recent time, more research institutes and hospitals are investing in proton therapy to make the technology more accessible to patients.
In this report we have studied the market in two parts: a) Actual Market and b) Potential Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.
Key Companies Covered:
- IBA (Overview, Sales Analysis)
- Varian Medical Systems (Overview, Sales Analysis)
- Elekta (Overview, Sales Analysis)
Key Topics Covered:
1. Executive Summary
2. United States Proton Therapy Market - Actual & Potential Market
2.1 United States - Proton Therapy Market
2.2 United States - Potential Proton Therapy Market & Forecast
3. United States Proton Therapy Patient Number - Actual and Potential
3.1 United States - Patients Treated with Proton Therapy Actual Numbers & Forecast
3.2 United States - Patients with Proton Therapy Potential Numbers & Forecast
4. United States - List of Proton Therapy Centers
5. United States - Proton Therapy Treated Patients by Centers
5.1 Loma Linda (LLUMC) Proton Therapy Center - Number of Patients Treated (2008 - 2014)
5.2 UCSF - CNL Proton Therapy Center - Number of Patients Treated (2008 - 2015)
5.3 Boston (NPTC) Proton Therapy Center - Number of Patients Treated (2008 - 2015)
5.4 Bloomington (MPRI, 2) Proton Therapy Center - Number of Patients Treated (2008 - 2014)
5.5 Houston (MD Anderson) Proton Therapy Center - Number of Patients Treated (2008 - 2015)
5.6 UFPTI Jacksonville Proton Therapy Center - Number of Patients Treated (2008 - 2015)
5.7 Oklahoma City (ProCure PTC) Proton Therapy Center - Number of Patients Treated (2009 - 2015)
5.8 CDH Warrenville Proton Therapy Center - Number of Patients Treated (2010 - 2015)
5.9 Philadelphia (Upenn) Proton Therapy Center - Number of Patients Treated (2011 - 2015)
5.10 Hampton (HUPTI) Proton Therapy Center - Number of Patients Treated (2012 - 2015)
5.11 New Jersey (ProCure PTC) Proton Therapy Center - Number of Patients Treated (2012 - 2015)
5.12 Seattle (SCCA ProCure PTC) Proton Therapy Center - Number of Patients Treated (2013 - 2015)
5.13 St. Louis (S. Lee King PTC) Proton Therapy Center - Number of Patients Treated (2013 - 2015)
5.14 Provision Center for Proton Therapy, Knoxville, TN - Number of Patients Treated (2014 - 2015)
5.15 San Diego (Scripps PTC) - Number of Patients Treated (2014 - 2015)
5.16 Shreveport (Willis Knighton) Proton Therapy Center - Number of Patients Treated (2014 - 2015)
5.17 Jacksonville (Ackerman CC) Proton Therapy Center - Number of Patients Treated (2015)
5.18 Rochester (Mayo PBTC) Proton Therapy Center - Number of Patients Treated (2015)
5.19 Brunswick (Laurie PC) Proton Therapy Center - Number of Patients Treated (2015)
5.20 Irving (Texas Center for PT) Proton Therapy Center - Number of Patients Treated (2015)
5.21 Memphis (St. Jude PTC) Proton Therapy Center - Number of Patients Treated (2015)
6. Proton Therapy - Reimbursement Policies
6.1 Proton Therapy Reimbursement Policies for Patients
6.2 Proton Therapy Reimbursement for Institutions, Stakeholders and Manufacturers
7. Components of a Standard Proton Therapy Center
7.1 Proton Accelerator
7.1.1 Synchrotrons (example: LLUMC at Loma Linda)
7.1.2 Cyclotrons (example: MGH Boston)
7.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
7.1.4 Linacs (Rome)
7.1.5 H-minus Synchrotrons
7.1.6 Separated Sector Cyclotrons
7.1.7 Super-conducting Cyclotrons
7.1.8 Fast Cycling Synchrotron
7.2 Beam Transport System
7.3 Beam Delivery System
7.3.1 The Passive Scattering Technique
7.3.2 Beam Scanning
7.4 Nozzle
7.4.1 Single Scattering
7.4.2 Double Scattering
7.4.3 Uniform Scanning Nozzle
7.4.4 Pencil Scanning Nozzle
7.5 Treatment Planning System
7.6 Image Viewers
7.7 Patient Positioning System (PPS)
7.8 Human Resource
8. Global Proton Therapy - Company Analysis (2010-2021)
8.1 IBA Proton Therapy
8.1.1 Sales Analysis
8.2 Varian Medical Systems
8.2.1 Sales Analysis
8.3 Elekta
8.3.1 Sales Analysis
9. Proton Therapy - Driving Factors
9.1 Technology Advancement
9.2 Growing Incidence of Cancer Patients in United States
10. Proton Therapy - Challenges
10.1 Requires Huge Investment
10.2 Operations Challenges
For more information about this report visit
http://www.researchandmarkets.com/research/38mcvc/united_states
Media Contact:
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article